These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 19619928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [In vitro activity of amphotericin B, fluconazole and itraconazole against Candida glabrata strains isolated from clinical samples].
    Hüseyin A, Sancak B, Arikan S.
    Mikrobiyol Bul; 2007 Apr; 41(2):235-44. PubMed ID: 17682710
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome-wide expression studies.
    Vermitsky JP, Earhart KD, Smith WL, Homayouni R, Edlind TD, Rogers PD.
    Mol Microbiol; 2006 Aug; 61(3):704-22. PubMed ID: 16803598
    [Abstract] [Full Text] [Related]

  • 8. Current treatment options for vulvovaginal candidiasis caused by azole-resistant Candida species.
    Sobel JD, Sobel R.
    Expert Opin Pharmacother; 2018 Jun; 19(9):971-977. PubMed ID: 29932786
    [Abstract] [Full Text] [Related]

  • 9. Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis.
    Odabasi Z, Paetznick VL, Rodriguez JR, Chen E, Rex JH, Leitz GJ, Ostrosky-Zeichner L.
    Mycoses; 2010 Sep; 53(5):438-42. PubMed ID: 19500259
    [Abstract] [Full Text] [Related]

  • 10. Azole resistance of Candida glabrata in a case of recurrent fungemia.
    Posteraro B, Tumbarello M, La Sorda M, Spanu T, Trecarichi EM, De Bernardis F, Scoppettuolo G, Sanguinetti M, Fadda G.
    J Clin Microbiol; 2006 Aug; 44(8):3046-7. PubMed ID: 16891541
    [Abstract] [Full Text] [Related]

  • 11. In vitro susceptibility of oral Candida to seven antifungal agents.
    Kuriyama T, Williams DW, Bagg J, Coulter WA, Ready D, Lewis MA.
    Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recurrent vulvovaginal candidiasis.
    Ringdahl EN.
    Mo Med; 2006 Dec; 103(2):165-8. PubMed ID: 16703718
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ, Horn DL, Neofytos D, Pfaller MA, Diekema DJ, PATH Alliance.
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):152-7. PubMed ID: 19376667
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Impact of antifungal prophylaxis on colonization and azole susceptibility of Candida species.
    Mann PA, McNicholas PM, Chau AS, Patel R, Mendrick C, Ullmann AJ, Cornely OA, Patino H, Black TA.
    Antimicrob Agents Chemother; 2009 Dec; 53(12):5026-34. PubMed ID: 19786600
    [Abstract] [Full Text] [Related]

  • 20. Antifungal susceptibility testing of micafungin against Candida glabrata isolates.
    Oliveira ER, Fothergill A, Kirkpatrick WR, Patterson TF, Redding SW.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Apr; 105(4):457-9. PubMed ID: 18329581
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.